Pulse Biosciences, Inc Common Stock (DE) vs. Stryker Corporation
PLSE
Pulse Biosciences, Inc Common Stock (DE)
$53.87 +6.44%
VS SYKStryker Corporation
$275.12 -1.79%
Stryker Corporation (SYK) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| PLSE | SYK | |
|---|---|---|
| Market Cap | $3.84 billion | $105.53 billion |
| Revenue (TTM) | $1.19 million | $25.84 billion |
| Net Income (TTM) | $-80,056,000 | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| PLSE | SYK | |
|---|---|---|
| P/E Ratio | — | 28.51 |
| Price / Book | 38.61 | 4.40 |
| Price / Sales | 3242.32 | 4.08 |
SYK leads on 2 of 2 valuation factors.
Profitability
| PLSE | SYK | |
|---|---|---|
| Net Margin | -6755.78% | 14.43% |
| Return on Equity | -80.46% | 15.55% |
SYK leads on 2 of 2 profitability factors.
Dividend
| PLSE | SYK | |
|---|---|---|
| Dividend Yield | — | 1.28% |
| Payout Ratio | — | 36.48 |
PLSE and SYK split the dividend factors evenly.
Risk & Sentiment
| PLSE | SYK | |
|---|---|---|
| Short Interest | 2.24% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: PLSE overview, PLSE financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.